[1] JENSEN G E, HANSEN M L. Occupational arsenic exposure and glycosylated haemoglobin[J]. Analyst, 1998, 123(1):77-80. [2] SELTENRICH N. Arsenic and diabetes:assessing risk at low-to-moderate exposures[J]. Environ Health Perspect, 2018, 126(4):044002. [3] NEWMAN J D, NAVAS-ACIEN A, KUO C C, et al. Peripheral arterial disease and its association with arsenic exposure and metabolism in the strong heart study[J]. Am J Epidemiol, 2016, 184(11):806-817. [4] 韦炳干, 高健伟, 柴园庆, 等. 饮水型砷中毒病区人群砷暴露量及尿砷的季节变化[J]. 生态毒理学报, 2016, 11(4):204-210. [5] 丁春光, 潘亚娟, 张爱华, 等. 中国八省份一般人群血和尿液中砷水平及影响因素调查[J]. 中华预防医学杂志, 2014, 48(2):97-101. [6] FESEKE S K, ST-LAURENT J, ANASSOUR-SIDI E, et al. Arsenic exposure and type 2 diabetes:results from the 2007-2009 Canadian Health Measures Survey[J]. Health Promot Chronic Dis Prev Can, 2015, 35(4):63-72. [7] WEI H Y, HU Q Y, WU J X, et al. Molecular mechanism of the increased tissue uptake of trivalent inorganic arsenic in mice with type 1 diabetes mellitus[J]. Biochem Biophys Res Commun, 2018, 504(2):393-399. [8] 李萌, 罗樱樱, 杨晓燕, 等. 年龄对糖化血红蛋白和糖化血清白蛋白筛查糖尿病的影响[J]. 中国糖尿病杂志, 2015, 23(5):385-389. [9] 赵剑敏, 陈樱花. 糖尿病患者高糖化血红蛋白的影响因素分析[J]. 中国当代医药, 2019, 26(24):125-127. [10] 丘永平, 张运超, 徐悦和. 糖尿病患者糖化血红蛋白水平变化对高血压及冠心病的临床影响分析[J]. 临床和实验医学杂志, 2018, 17(2):166-169. [11] 李贵, 金铃胆, 林宝英, 等. 糖化血红蛋白对高血压患者血压变异性和颈动脉硬化的影响[J]. 中华高血压杂志, 2018, 26(12):1182-1185. [12] VELMURUGAN G, SWAMINATHAN K, VEERASEKAR G, et al. Metals in urine in relation to the prevalence of pre-diabetes, diabetes and atherosclerosis in rural India[J]. Occup Environ Med, 2018, 75(9):661-667. [13] 伍晓聪, 武革. 糖化血红蛋白与糖尿病肾病[J]. 中国临床新医学, 2018, 11(1):97-100. [14] 荣秀花, 黄亚莉, 李小景, 等. 健康人群糖化血红蛋白水平及其与年龄的相关性[J]. 现代医学, 2015, 43(6):694-697. [15] 陈伟, 张红梅, 陈丹, 等. 2型糖尿病患者糖血红蛋白水平与胰岛素分泌关系研究[J]. 临床和实验医学杂志, 2016, 15(10):981-983. [16] REHMAN K, FATIMA F, AKASH M S H. Biochemical investigation of association of arsenic exposure with risk factors of diabetes mellitus in Pakistani population and its validation in animal model[J]. Environ Monit Assess, 2019, 191(8):511. |